“…Notably, no significant differences in AKI ratio and ventilation percentage during hospitalization were found in the matched cohort (p = 0.121 and p = 0.175, respectively). Meanwhile, patients with ACEI/ARB exposure had lower serum F I G U R E 1 Flowchart of patient selection MIMIC-III Data Hospitalized patients with acute respiratory failure (ICD-9: 51881) between 2001 to 2012, n=7,497 First admission for acute respiratory failure, n=5,389 Adult patients with acute respiratory failure, n=5,335 -2,108 -54 Keep only the first admission for patients with acute respiratory failure (n=2,108) Non-ACEI and ARB users, n=4,972 Exclude Patient age<18 years (n=4) No laboratory data (n=50) Non-ACEI and ARB users, n=1,401 ACEI or ARB users, n=363 ACEI or ARB users, n=363 PSM method MIMIC-III = Medical Information Mart for Intensive Care-III ICD-9 = International classification of diseases-9 ACEI = Angiotensin converting enzyme inhibitors ARB = Angiotensin receptor blockers PSM = Propensity score matchingcreatinine and BUN levels in the matched cohort (1.2 (0.9, 1.8) mg/ dl vs. 1.3 (0.9, 2.2) mg/dl, p = 0.003 and 26(18,44) mg/dl vs. 31(20, 50) mg/dl, p < 0.001), respectively, which did not occur in the original cohort.…”